Participants 57 146 7
chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease:
Participants 366 420 5
pediatric and adolescent patients with Hodgkin disease
Participants 422 547 7
Children < or =21 years old with biopsy-proven, pathologically staged I, IIA, or IIIA1 Hodgkin disease were randomly assigned
